Amyloid precursor protein

From Wikipedia, the free encyclopedia
Jump to: navigation, search
"APPI" redirects here. For the former Professional Association of Independent Phonographic Producers, see UPFI.
Amyloid beta (A4) precursor protein
PBB Protein APP image.jpg
PDB rendering based on 1aap[1]
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols APP ; AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2
External IDs OMIM104760 MGI88059 HomoloGene56379 ChEMBL: 2487 GeneCards: APP Gene
RNA expression pattern
PBB GE APP 200602 at.png
PBB GE APP 211277 x at.png
PBB GE APP 214953 s at.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 351 11820
Ensembl ENSG00000142192 ENSMUSG00000022892
UniProt P05067 P12023
RefSeq (mRNA) NM_000484 NM_001198823
RefSeq (protein) NP_000475 NP_001185752
Location (UCSC) Chr 21:
27.25 – 27.54 Mb
Chr 16:
84.95 – 85.17 Mb
PubMed search [1] [2]
The metal-binding domain of APP with a bound copper ion. The side chains of the two histidine and one tyrosine residues that play a role in metal coordination are shown in the Cu(I) bound, Cu(II) bound, and unbound conformations, which differ by only small changes in orientation.
The extracellular E2 domain, a dimeric coiled coil and one of the most highly-conserved regions of the protein from Drosophila to humans. This domain, which resembles the structure of spectrin, is thought to bind heparan sulfate proteoglycans.[2]
(a) A low magnification image immediately after co-injection of red negatively charged and green glycine-conjugated beads showing the injection site, marked with an oil droplet, appearing as a round yellow sphere. Overlap of red and green fluorescence produces a yellow image. (b) At 50 min after injection, the red carboxylated beads have progressed in the anterograde direction (to the right) while the green glycine-conjugated beads have made no progress. (c)–(e) An axon co-injected with red APP-C beads and green glycine beads and imaged for 100 frames at 4 s intervals at 40× magnification. (c) Red channel (left) first frame; (center) 50 frames superimposed; (right) all 100 frames superimposed. Note the progression of individual beads towards the right, anterograde, side of the injection site heading towards the presynaptic terminal. (d) Two images of the green channel from the same video sequence; (left) first frame; (center) 100 frames superimposed. Note the lack of significant movement of the green glycine beads. (e) Both red and green channels from 100 frames superimposed of the same video as in (c) and (d). (f) Single bead trajectories at high magnification from a set of superimposed frames showing movements of beads.

Amyloid precursor protein (APP) is an integral membrane protein expressed in many tissues and concentrated in the synapses of neurons. Its primary function is not known, though it has been implicated as a regulator of synapse formation,[3] neural plasticity[4] and iron export.[5] APP is best known as the precursor molecule whose proteolysis generates beta amyloid (Aβ), a 37 to 49 amino acid peptide whose amyloid fibrillar form is the primary component of amyloid plaques found in the brains of Alzheimer's disease patients.

Genetics[edit]

APP is an ancient and highly conserved protein.[6] In humans, the gene for APP is located on chromosome 21 and contains at least 18 exons in 240 kilobases.[7][8] Several alternative splicing isoforms of APP have been observed in humans, ranging in length from 365 to 770 amino acids, with certain isoforms preferentially expressed in neurons; changes in the neuronal ratio of these isoforms have been associated with Alzheimer's disease.[9] Homologous proteins have been identified in other organisms such as Drosophila (fruit flies), C. elegans (roundworms), and all mammals.[10] The amyloid beta region of the protein, located in the membrane-spanning domain, is not well conserved across species and has no obvious connection with APP's native-state biological functions.[10]

Mutations in critical regions of Amyloid Precursor Protein, including the region that generates amyloid beta (Aβ), cause familial susceptibility to Alzheimer's disease.[11][12][13] For example, several mutations outside the Aβ region associated with familial Alzheimer's have been found to dramatically increase production of Aβ.[14]

A mutation (A673T) in the APP gene protects against Alzheimer’s disease. This substitution is adjacent to the beta secretase cleavage site and results in a 40% reduction in the formation of amyloid beta in vitro.[15]

Structure[edit]

A number of distinct, largely independently-folding structural domains have been identified in the APP sequence. The extracellular region, much larger than the intracellular region, is divided into the E1 and E2 domains, linked by an acidic domain (AcD); E1 contains two subdomains including a growth factor-like domain (GFLD) and a copper-binding domain (CuBD) interacting tightly together.[16] A serine protease inhibitor domain, absent from the isoform differentially expressed in the brain, is found between acidic region and E2 domain.[17] The complete crystal structure of APP has not yet been solved; however, individual domains have been successfully crystallized, the growth factor-like domain,[18] the copper-binding domain,[19] the complete E1 domain[16] and the E2 domain.[2]

Post-translational processing[edit]

APP undergoes extensive post-translational modification including glycosylation, phosphorylation, and tyrosine sulfation, as well as many types of proteolytic processing to generate peptide fragments.[20] It is commonly cleaved by proteases in the secretase family; alpha secretase and beta secretase both remove nearly the entire extracellular domain to release membrane-anchored carboxy-terminal fragments that may be associated with apoptosis.[10] Cleavage by gamma secretase within the membrane-spanning domain after beta-secretase cleavage generates the amyloid-beta fragment; gamma secretase is a large multi-subunit complex whose components have not yet been fully characterized, but include presenilin, whose gene has been identified as a major genetic risk factor for Alzheimer's.[21]

The amyloidogenic processing of APP has been linked to its presence in lipid rafts. When APP molecules occupy a lipid raft region of membrane, they are more accessible to and differentially cleaved by beta secretase, whereas APP molecules outside a raft are differentially cleaved by the non-amyloidogenic alpha secretase.[22] Gamma secretase activity has also been associated with lipid rafts.[23] The role of cholesterol in lipid raft maintenance has been cited as a likely explanation for observations that high cholesterol and apolipoprotein E genotype are major risk factors for Alzheimer's disease.[24]

Biological function[edit]

Although the native biological role of APP is of obvious interest to Alzheimer's research, thorough understanding has remained elusive.

Synaptic formation and repair[edit]

The most-substantiated role for APP is in synaptic formation and repair;[3] its expression is upregulated during neuronal differentiation and after neural injury. Roles in cell signaling, long-term potentiation, and cell adhesion have been proposed and supported by as-yet limited research.[10] In particular, similarities in post-translational processing have invited comparisons to the signaling role of the surface receptor protein Notch.[25]

APP knockout mice are viable and have relatively minor phenotypic effects including impaired long-term potentiation and memory loss without general neuron loss.[26] On the other hand, transgenic mice with upregulated APP expression have also been reported to show impaired long-term potentiation.[27]

The logical inference is that because Aβ accumulates excessively in Alzheimer's disease its precursor, APP, would be elevated as well. However, neuronal cell bodies contain less APP as a function of their proximity to amyloid plaques.[28] The data indicate that this deficit in APP results from a decline in production rather than an increase in catalysis. Loss of a neuron's APP may affect physiological deficits that contribute to dementia.

Anterograde neuronal transport[edit]

Molecules synthesized in the cell bodies of neurons must be conveyed to the outward to distal synapses. This is accomplished via fast anterograde transport. It has been found that APP can mediate interaction between cargo and kinesin and thus facilitate this transport. Specifically, a short peptide 15-amino-acid sequence from the cytoplasmic carboxy-terminus is necessary for interaction with the motor protein.[29]

Additionally, it has been shown that the interaction between APP and kinesin is specific to the peptide sequence of APP. In a recent experiment involving transport of peptide-conjugated colored beads, controls were conjugated to a single amino acid, glycine, such that they display the same terminal carboxylic acid group as APP without the intervening 15-amino-acid sequence mentioned above. The control beads were not motile, which demonstrated that the terminal COOH moiety of peptides is not sufficient to mediate transport.[30]

Iron export[edit]

A different perspective on Alzheimer's is revealed by a mouse study that has found that APP possesses ferroxidase activity similar to ceruloplasmin, facilitating iron export through interaction with ferroportin; it seems that this activity is blocked by zinc trapped by accumulated Aβ in Alzheimer's.[5] It has been shown that a single nucleotide polymorphism in the 5'UTR of APP mRNA can disrupt its translation.[31]

The hypothesis that APP has ferroxidase activity in its E2 domain and facilitates export of Fe(II) is possibly incorrect since the proposed ferroxidase site of APP located in the E2 domain does not have ferroxidase activity.[32][33]

As APP does not possess ferroxidase activity within its E2 domain, the mechanism of APP-modulated iron efflux from ferroportin has come under scrutiny. One model suggests that APP acts to stabilize the iron efflux protein ferroportin in the plasma membrane of cells thereby increasing the total number of ferroportin molecules at the membrane. These iron-transporters can then be activated by known mammalian ferroxidases (i.e. ceruloplasmin or hephaestin). [34]

Hormonal regulation[edit]

The amyloid-β precursor protein (AβPP) and all associated secretases are expressed early in development and plays a key role in the endocrinology of reproduction – with the differential processing of AβPP by secretases regulating human embryonic stem cell (hESC) proliferation as well as their differentiation into neural precursor cells (NPC). The pregnancy hormone human chorionic gonadotropin (hCG) increases AβPP expression[35] and hESC proliferation while progesterone directs AβPP processing towards the non-amyloidogenic pathway, which promotes hESC differentiation into NPC.[36][37][38]

AβPP and its cleavage products do not promote the proliferation and differentiation of post-mitotic neurons; rather, the overexpression of either wild-type or mutant AβPP in post-mitotic neurons induces apoptotic death following their re-entry into the cell cycle.[39] It is postulated that the loss of sex steroids (including progesterone) but the elevation in luteinizing hormone, the adult equivalent of hCG, post-menopause and during andropause drives amyloid-β production[40] and re-entry of post-mitotic neurons into the cell cycle.

Arthritis[edit]

Recently, amyloid precursor protein (APP) origin was demonstrated with arthritogenic animals. The source noted is breakdown of immune complexes, where the amyloid aggregates are left degraded and bind together to form coil like structures that are not resorbed. Also, it induces secondary inflammation, which may cause local damage.[41]

Interactions[edit]

Amyloid precursor protein has been shown to interact with:

APP interacts with reelin, a protein implicated in a number of brain disorders, including Alzheimer's disease.[62]

References[edit]

  1. ^ Hynes, T. R.; Randal, M.; Kennedy, L. A.; Eigenbrot, C.; Kossiakoff, A. A. (1990). "X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor". Biochemistry 29 (43): 10018–10022. doi:10.1021/bi00495a002. PMID 2125487.  edit
  2. ^ a b PDB 1RW6; Wang Y, Ha Y (August 2004). "The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain". Mol. Cell 15 (3): 343–53. doi:10.1016/j.molcel.2004.06.037. PMID 15304215. 
  3. ^ a b Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (July 2006). "Synapse formation and function is modulated by the amyloid precursor protein". J. Neurosci. 26 (27): 7212–21. doi:10.1523/JNEUROSCI.1450-06.2006. PMID 16822978. 
  4. ^ Turner PR, O'Connor K, Tate WP, Abraham WC (May 2003). "Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory". Prog. Neurobiol. 70 (1): 1–32. doi:10.1016/S0301-0082(03)00089-3. PMID 12927332. 
  5. ^ a b Duce JA et al (2010). "Iron-Export Ferroxidase Activity of β- Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease". Cell 142 (6): 857–67. doi:10.1016/j.cell.2010.08.014. PMC 2943017. PMID 20817278. 
  6. ^ Sarkar IN, Tharp G (April 2013). "Origins of amyloid-beta.". BMC Genomics 14 (1): 290. doi:10.1186/1471-2164-14-290. PMID 23627794. 
  7. ^ Yoshikai S, Sasaki H, Doh-ura K, Furuya H, Sakaki Y (March 1990). "Genomic organization of the human amyloid beta-protein precursor gene". Gene 87 (2): 257–63. doi:10.1016/0378-1119(90)90310-N. PMID 2110105. 
  8. ^ Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD (September 1993). "Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]". Nat. Genet. 5 (1): 22–30. doi:10.1038/ng0993-22. PMID 8220418. 
  9. ^ Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT (August 2007). "Expression of APP pathway mRNAs and proteins in Alzheimer's disease". Brain Res. 1161: 116–23. doi:10.1016/j.brainres.2007.05.050. PMID 17586478. 
  10. ^ a b c d Zheng H, Koo EH (2006). "The amyloid precursor protein: beyond amyloid". Mol Neurodegener 1 (1): 5. doi:10.1186/1750-1326-1-5. PMC 1538601. PMID 16930452. 
  11. ^ Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L (February 1991). "Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease". Nature 349 (6311): 704–6. doi:10.1038/349704a0. PMID 1671712. 
  12. ^ Murrell J, Farlow M, Ghetti B, Benson MD (October 1991). "A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease". Science 254 (5028): 97–9. doi:10.1126/science.1925564. PMID 1925564. 
  13. ^ Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J (October 1991). "Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene". Nature 353 (6347): 844–6. doi:10.1038/353844a0. PMID 1944558. 
  14. ^ Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (December 1992). "Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production". Nature 360 (6405): 672–4. doi:10.1038/360672a0. PMID 1465129. 
  15. ^ Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (July 2012). "A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline". Nature 487 (7409): 96–9. doi:10.1038/nature11283. PMID 22801501. Lay summaryThe New York Times. 
  16. ^ a b Dahms SO, Hoefgen S, Roeser D, Schlott B, Gührs KH, Than ME (March 2010). "Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein". Proc Natl Acad Sci U S A 107 (12): 5381–6. doi:10.1073/pnas.0911326107. PMC 2851805. PMID 20212142. ; see also PDB ID 3KTM
  17. ^ Sisodia SS, Koo EH, Hoffman PN, Perry G, Price DL (July 1993). "Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system". J. Neurosci. 13 (7): 3136–42. PMID 8331390. 
  18. ^ Rossjohn J, Cappai R, Feil SC, Henry A, McKinstry WJ, Galatis D, Hesse L, Multhaup G, Beyreuther K, Masters CL, Parker MW (April 1999). "Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein". Nat Struct Biol 6 (4): 327–31. doi:10.1038/7562. PMID 10201399. ; see also PDB ID 1MWP
  19. ^ Kong GK, Adams JJ, Harris HH, Boas JF, Curtain CC, Galatis D, Masters CL, Barnham KJ, McKinstry WJ, Cappai R, Parker MW (March 2007). "Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions". J Mol Biol 367 (1): 148–61. doi:10.1016/j.jmb.2006.12.041. PMID 17239395. ; See also 2007 PDB IDs 2FJZ, 2FK2, 2FKL.
  20. ^ De Strooper B, Annaert W (June 2000). "Proteolytic processing and cell biological functions of the amyloid precursor protein". J. Cell. Sci. ( Pt 11): 1857–70. PMID 10806097. 
  21. ^ Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, Gu Y, Sanjo N, Glista M, Rogaeva E, Wakutani Y, Pardossi-Piquard R, Ruan X, Tandon A, Checler F, Marambaud P, Hansen K, Westaway D, St George-Hyslop P, Fraser P (April 2006). "TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity". Nature 440 (7088): 1208–12. doi:10.1038/nature04667. PMID 16641999. 
  22. ^ Ehehalt R, Keller P, Haass C, Thiele C, Simons K (January 2003). "Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts". J. Cell Biol. 160 (1): 113–23. doi:10.1083/jcb.200207113. PMC 2172747. PMID 12515826. 
  23. ^ Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H, Thinakaran G (October 2004). "Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes". J. Biol. Chem. 279 (43): 44945–54. doi:10.1074/jbc.M407986200. PMC 1201506. PMID 15322084. 
  24. ^ Riddell DR, Christie G, Hussain I, Dingwall C (August 2001). "Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts". Curr. Biol. 11 (16): 1288–93. doi:10.1016/S0960-9822(01)00394-3. PMID 11525745. 
  25. ^ Selkoe D, Kopan R (2003). "Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration". Annu. Rev. Neurosci. 26 (1): 565–97. doi:10.1146/annurev.neuro.26.041002.131334. PMID 12730322. 
  26. ^ Phinney AL, Calhoun ME, Wolfer DP, Lipp HP, Zheng H, Jucker M (1999). "No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice". Neuroscience 90 (4): 1207–16. doi:10.1016/S0306-4522(98)00645-9. PMID 10338291. 
  27. ^ Matsuyama S, Teraoka R, Mori H, Tomiyama T. (2007). Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice. Neuroreport 18(10):1083-7. PMID 17558301
  28. ^ Barger SW, DeWall KM, Liu L, Mrak RE, Griffin WS (August 2008). "Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies". J. Neuropathol. Exp. Neurol. 67 (8): 773–83. doi:10.1097/NEN.0b013e318180ec47. PMC 3334532. PMID 18648325. 
  29. ^ Satpute-Krishnan, P.; Degiorgis, J. A.; Conley, M. P.; Jang, M.; Bearer, E. L. (2006). "A peptide zipcode sufficient for anterograde transport within amyloid precursor protein". Proceedings of the National Academy of Sciences 103 (44): 16532. doi:10.1073/pnas.0607527103. 
  30. ^ Seamster, P. E.; Loewenberg, M.; Pascal, J.; Chauviere, A.; Gonzales, A.; Cristini, V.; Bearer, E. L. (2012). "Quantitative measurements and modeling of cargo–motor interactions during fast transport in the living axon". Physical Biology 9 (5): 055005. doi:10.1088/1478-3975/9/5/055005. PMC 3625656. PMID 23011729. 
  31. ^ Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, Cahill CM (December 2008). "Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease". Biochem. Soc. Trans. 36 (Pt 6): 1282–7. doi:10.1042/BST0361282. PMC 2746665. PMID 19021541. 
  32. ^ Ebrahimi KH, Hagedoorn PL, Hagen WR (2012). "A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron". PLoS ONE 7 (8): e40287. doi:10.1371/journal.pone.0040287. PMC 3419245. PMID 22916096. 
  33. ^ Honarmand Ebrahimi K, Dienemann C, Hoefgen S, Than ME, Hagedoorn PL, Hagen WR (2013). "The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain". PLoS ONE 8 (8): e72177. doi:10.1371/journal.pone.0072177. PMID 23977245. 
  34. ^ McCarthy, RC; Park, YH; Kosman, DJ (May 27, 2014). "sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin". EMBO Reports. doi:10.15252/embr.201338064. 
  35. ^ Porayette P, Gallego MJ, Kaltcheva MM, Meethal SV, Atwood CS (December 2007). "Amyloid-beta precursor protein expression and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin". Biochem. Biophys. Res. Commun. 364 (3): 522–7. doi:10.1016/j.bbrc.2007.10.021. PMID 17959150. 
  36. ^ Porayette P, Gallego MJ, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS (August 2009). "Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells". J. Biol. Chem. 284 (35): 23806–17. doi:10.1074/jbc.M109.026328. PMC 2749153. PMID 19542221. 
  37. ^ Gallego MJ, Porayette P, Kaltcheva MM, Meethal SV, Atwood CS (June 2009). "Opioid and progesterone signaling is obligatory for early human embryogenesis". Stem Cells Dev. 18 (5): 737–40. doi:10.1089/scd.2008.0190. PMC 2891507. PMID 18803462. 
  38. ^ Gallego MJ, Porayette P, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS (2010). "The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes". Stem Cell Res Ther 1 (4): 28. doi:10.1186/scrt28. PMC 2983441. PMID 20836886. 
  39. ^ McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly SP, Kozlowski MR, Neve KA, Neve RL (July 2003). "DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3". J. Neurosci. 23 (17): 6914–27. PMID 12890786. 
  40. ^ Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS (May 2004). "Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition". J. Biol. Chem. 279 (19): 20539–45. doi:10.1074/jbc.M311993200. PMID 14871891. 
  41. ^ Subramanian S (January 2010). "Immunological and Biochemical factors in amyloidosis of adjuvant arthritic rats". Asian Journal of Experimental Biological Sciences 24 (1): 101–105. 
  42. ^ a b c Biederer T, Cao Xinwei, Südhof Thomas C, Liu Xinran (September 2002). "Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms". J. Neurosci. 22 (17): 7340–51. PMID 12196555. 
  43. ^ a b Borg JP, Ooi J, Levy E, Margolis B (November 1996). "The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein". Mol. Cell. Biol. 16 (11): 6229–41. PMC 231626. PMID 8887653. 
  44. ^ a b Araki Y, Tomita Susumu, Yamaguchi Haruyasu, Miyagi Naomi, Sumioka Akio, Kirino Yutaka, Suzuki Toshiharu (Dec 2003). "Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism". J. Biol. Chem. 278 (49): 49448–58. doi:10.1074/jbc.M306024200. PMID 12972431. 
  45. ^ Tomita S, Ozaki T, Taru H, Oguchi S, Takeda S, Yagi Y, Sakiyama S, Kirino Y, Suzuki T (January 1999). "Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein". J. Biol. Chem. 274 (4): 2243–54. doi:10.1074/jbc.274.4.2243. PMID 9890987. 
  46. ^ Tanahashi H, Tabira T (February 1999). "X11L2, a new member of the X11 protein family, interacts with Alzheimer's beta-amyloid precursor protein". Biochem. Biophys. Res. Commun. 255 (3): 663–7. doi:10.1006/bbrc.1999.0265. PMID 10049767. 
  47. ^ Zambrano N, Buxbaum J D, Minopoli G, Fiore F, De Candia P, De Renzis S, Faraonio R, Sabo S, Cheetham J, Sudol M, Russo T (March 1997). "Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins". J. Biol. Chem. 272 (10): 6399–405. doi:10.1074/jbc.272.10.6399. PMID 9045663. 
  48. ^ Guénette SY, Chen J, Jondro P D, Tanzi R E (October 1996). "Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein". PNAS 93 (20): 10832–7. doi:10.1073/pnas.93.20.10832. PMC 38241. PMID 8855266. 
  49. ^ Tanahashi H, Tabira T (February 1999). "Molecular cloning of human Fe65L2 and its interaction with the Alzheimer's beta-amyloid precursor protein". Neurosci. Lett. 261 (3): 143–6. doi:10.1016/S0304-3940(98)00995-1. PMID 10081969. 
  50. ^ Trommsdorff M, Borg J P, Margolis B, Herz J (Dec 1998). "Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein". J. Biol. Chem. 273 (50): 33556–60. doi:10.1074/jbc.273.50.33556. PMID 9837937. 
  51. ^ Chow N, Korenberg J R, Chen X N, Neve R L (May 1996). "APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein". J. Biol. Chem. 271 (19): 11339–46. doi:10.1074/jbc.271.19.11339. PMID 8626687. 
  52. ^ Zheng P, Eastman J, Vande Pol S, Pimplikar S W (Dec 1998). "PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein". PNAS 95 (25): 14745–50. doi:10.1073/pnas.95.25.14745. PMC 24520. PMID 9843960. 
  53. ^ Wang B, Nguyen Mai, Breckenridge David G, Stojanovic Marina, Clemons Paul A, Kuppig Stephan, Shore Gordon C (April 2003). "Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria". J. Biol. Chem. 278 (16): 14461–8. doi:10.1074/jbc.M209684200. PMID 12529377. 
  54. ^ Lefterov IM, Koldamova R P, Lazo J S (September 2000). "Human bleomycin hydrolase regulates the secretion of amyloid precursor protein". FASEB J. 14 (12): 1837–47. doi:10.1096/fj.99-0938com. PMID 10973933. 
  55. ^ Araki Y, Miyagi Naomi, Kato Naoko, Yoshida Tomohiro, Wada Sachiyo, Nishimura Masaki, Komano Hiroto, Yamamoto Tohru, De Strooper Bart, Yamamoto Kazuo, Suzuki Toshiharu (June 2004). "Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation". J. Biol. Chem. 279 (23): 24343–54. doi:10.1074/jbc.M401925200. PMID 15037614. 
  56. ^ Ikezu T, Trapp B D, Song K S, Schlegel A, Lisanti M P, Okamoto T (April 1998). "Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein". J. Biol. Chem. 273 (17): 10485–95. doi:10.1074/jbc.273.17.10485. PMID 9553108. 
  57. ^ Hashimoto T, Wakabayashi Tomoko, Watanabe Atsushi, Kowa Hisatomo, Hosoda Ritsuko, Nakamura Atsushi, Kanazawa Ichiro, Arai Takao, Takio Koji, Mann David M A, Iwatsubo Takeshi (April 2002). "CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV". EMBO J. 21 (7): 1524–34. doi:10.1093/emboj/21.7.1524. PMC 125364. PMID 11927537. 
  58. ^ Ohsawa I, Takamura C, Kohsaka S (March 2001). "Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function". J. Neurochem. 76 (5): 1411–20. doi:10.1046/j.1471-4159.2001.00144.x. PMID 11238726. 
  59. ^ Chauhan VP, Ray I, Chauhan A, Wisniewski H M (May 1999). "Binding of gelsolin, a secretory protein, to amyloid beta-protein". Biochem. Biophys. Res. Commun. 258 (2): 241–6. doi:10.1006/bbrc.1999.0623. PMID 10329371. 
  60. ^ Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D (October 1997). "An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease". Nature 389 (6652): 689–95. doi:10.1038/39522. PMID 9338779. 
  61. ^ Tarr PE, Roncarati Roberta, Pelicci Giuliana, Pelicci Pier Giuseppe, D'Adamio Luciano (May 2002). "Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc". J. Biol. Chem. 277 (19): 16798–804. doi:10.1074/jbc.M110286200. PMID 11877420. 
  62. ^ Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, Lee JY, Howell BW, Hyman BT, Pak DT, Bu G, Rebeck GW (June 2009). "Interaction of reelin with amyloid precursor protein promotes neurite outgrowth". J. Neurosci. 29 (23): 7459–73. doi:10.1523/JNEUROSCI.4872-08.2009. PMC 2759694. PMID 19515914. Lay summaryAlzheimer Research Forum. 

Further reading[edit]

External links[edit]